Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Pulmonx Corp. (LUNG) PT Raised to $16 at Canaccord Genuity
-
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Pulmonx Corp. (LUNG) PT Lowered to $15 at Canaccord Genuity
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Pulmonx to Present at Upcoming Investor Conferences
-
Pulmonx to Present at Upcoming Investor Conferences
-
Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Pulmonx (LUNG) IPO Opens 111% Higher
-
Pulmonx Corp (LUNG) Prices 10M Share Upsized IPO at $19/Sh
-
Pulmonx Corporation Announces Pricing of its Upsized Initial Public Offering
